CTAS · Insider Trading
Cintas Corp
Every open-market purchase and sale reported by CTAS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Ronald W Tysoe | Director | A | +101 deriv. | — |
| 2026-09-17 | Karen L Carnahan | Director | A | +17 deriv. | — |
| 2026-09-17 | Melanie W. Barstad | Director | A | +12 deriv. | — |
| 2026-09-17 | Robert E. Coletti | Director | A | +29 deriv. | — |
| 2026-08-13 | Jim Rozakis | President & COO | F | −4,041 | −$819.15K |
| 2026-08-12 | Jim Rozakis | President & COO | MIXED | +7,607 | +$1.54M |
| 2026-08-12 | Todd M. Schneider | CEO and Director | MIXED | +22,345 | +$4.53M |
| 2026-08-12 | Scott Garula | EVP & CFO | MIXED | +7,737 | +$1.57M |
| 2026-08-12 | Scott D Farmer | Executive Chairman | MIXED | −15,093 | −$3.06M |
| 2026-08-12 | David Brock Denton | EVP, Secretary & Gen Counsel | MIXED | +2,239 | +$453.87K |
| 2026-07-30 | Robert E. Coletti | Director | A | +116 deriv. | — |
| 2026-07-30 | Karen L Carnahan | Director | A | +133 deriv. | — |
| 2026-07-30 | Melanie W. Barstad | Director | A | +148 deriv. | — |
| 2026-07-23 | Ronald W Tysoe | Director | MIXED | — | −$872.29K |
| 2026-07-20 | Melanie W. Barstad | Director | MIXED | — | −$1.86M |
| 2026-07-06 | Scott Garula | VP & CFO | F | −249 | −$42.35K |
| 2026-06-17 | Melanie W. Barstad | Director | A | +11 deriv. | — |
| 2026-06-17 | Karen L Carnahan | Director | A | +17 deriv. | — |
| 2026-06-17 | Robert E. Coletti | Director | A | +28 deriv. | — |
| 2026-06-17 | Ronald W Tysoe | Director | A | +99 deriv. | — |
| 2026-04-22 | Ronald W Tysoe | Director | MIXED | — | −$834.70K |
| 2026-04-16 | Karen L Carnahan | Director | A | +163 deriv. | — |
| 2026-04-16 | Robert E. Coletti | Director | A | +141 deriv. | — |
| 2026-04-16 | Melanie W. Barstad | Director | A | +180 deriv. | — |
| 2026-04-13 | Robert E. Coletti | Director | M | +12,544 | +$339.46K |
| 2026-03-17 | Robert E. Coletti | Director | A | +25 deriv. | — |
| 2026-03-17 | Karen L Carnahan | Director | A | +15 deriv. | — |
| 2026-03-17 | Melanie W. Barstad | Director | A | +10 deriv. | — |
| 2026-03-17 | Ronald W Tysoe | Director | A | +89 deriv. | — |
| 2026-01-30 | Scott D Farmer | Executive Chairman | G | −10,400 | — |
| 2026-01-30 | Robert E. Coletti | Director | G | −5,200 | — |
| 2026-01-22 | Robert E. Coletti | Director | A | +129 deriv. | — |
| 2026-01-22 | Melanie W. Barstad | Director | A | +164 deriv. | — |
| 2026-01-22 | Karen L Carnahan | Director | A | +148 deriv. | — |
| 2025-12-30 | Scott D Farmer | Executive Chairman | MIXED | −1,593,766 | — |
| 2025-12-30 | Robert E. Coletti | Assistant Secretary | MIXED | −559,732 | — |
| 2025-12-17 | Melanie W. Barstad | Director | A | +3,400 deriv. | — |
| 2025-12-17 | Melanie W. Barstad | Director | A | +817 deriv. | — |
| 2025-12-17 | Karen L Carnahan | Director | A | +4,756 deriv. | — |
| 2025-12-17 | Karen L Carnahan | Director | A | +1,582 deriv. | — |
| 2025-12-17 | Robert E. Coletti | Assistant Secretary | A | +8,128 deriv. | — |
| 2025-12-17 | Robert E. Coletti | Assistant Secretary | A | +2,766 deriv. | — |
| 2025-12-17 | Robert E. Coletti | Assistant Secretary | A | +26 deriv. | — |
| 2025-12-17 | Ronald W Tysoe | Director | A | +11,482 deriv. | — |
| 2025-12-17 | Ronald W Tysoe | Director | A | +10,844 deriv. | — |
| 2025-12-17 | Ronald W Tysoe | Director | A | +7,530 deriv. | — |
| 2025-12-17 | Ronald W Tysoe | Director | A | +7,589 deriv. | — |
| 2025-12-17 | Ronald W Tysoe | Director | A | +1,202 deriv. | — |
| 2025-10-31 | Melanie W. Barstad | Director | A | +503 | — |
| 2025-10-31 | Beverly K Carmichael | Director | A | +503 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Todd M. Schneider | CEO and Director | 730,472 | $156.09M |
| Scott D Farmer | Executive Chairman | 423,419 | $90.48M |
| Robert E. Coletti | Director | 361,796 | $77.31M |
| Jim Rozakis | President & COO | 285,219 | $60.95M |
| Scott Garula | EVP & CFO | 105,515 | $22.55M |
| Joseph Scaminace | Director | 43,596 | $9.32M |
| David Brock Denton | EVP, Secretary & Gen Counsel | 32,178 | $6.88M |
| Ronald W Tysoe | Director | 26,811 | $5.73M |
| Melanie W. Barstad | Director | 26,592 | $5.68M |
| Karen L Carnahan | Director | 25,256 | $5.40M |
| Martin Mucci | Director | 3,124 | $667.57K |
| Beverly K Carmichael | Director | 1,340 | $286.34K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CTAS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.